Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor.
Vilquin P, Villedieu M, Grisard E, Ben Larbi S, Ghayad SE, Heudel PE, Bachelot T, Corbo L, Treilleux I, Vendrell JA, Cohen PA. Vilquin P, et al. Among authors: corbo l. Int J Cancer. 2013 Oct 1;133(7):1589-602. doi: 10.1002/ijc.28182. Epub 2013 May 2. Int J Cancer. 2013. PMID: 23553037
LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.
Bouchekioua-Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, Bachelot T, Chabaud S, Mader S, Dayan G, Treilleux I, Corbo L, Le Romancer M. Bouchekioua-Bouzaghou K, et al. Among authors: corbo l. Int J Cancer. 2014 Sep 15;135(6):1307-18. doi: 10.1002/ijc.28781. Epub 2014 Mar 4. Int J Cancer. 2014. PMID: 24615515
Activation of rapid oestrogen signalling in aggressive human breast cancers.
Poulard C, Treilleux I, Lavergne E, Bouchekioua-Bouzaghou K, Goddard-Léon S, Chabaud S, Trédan O, Corbo L, Le Romancer M. Poulard C, et al. Among authors: corbo l. EMBO Mol Med. 2012 Nov;4(11):1200-13. doi: 10.1002/emmm.201201615. Epub 2012 Oct 15. EMBO Mol Med. 2012. PMID: 23065768 Free PMC article.
LKB1 regulates PRMT5 activity in breast cancer.
Lattouf H, Kassem L, Jacquemetton J, Choucair A, Poulard C, Trédan O, Corbo L, Diab-Assaf M, Hussein N, Treilleux I, Le Romancer M. Lattouf H, et al. Among authors: corbo l. Int J Cancer. 2019 Feb 1;144(3):595-606. doi: 10.1002/ijc.31909. Epub 2018 Oct 31. Int J Cancer. 2019. PMID: 30289978 Free PMC article.
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes.
Teinturier R, Abou Ziki R, Kassem L, Luo Y, Malbeteau L, Gherardi S, Corbo L, Bertolino P, Bachelot T, Treilleux I, Zhang CX, Le Romancer M. Teinturier R, et al. Among authors: corbo l. Breast Cancer Res Treat. 2021 Dec;190(3):389-401. doi: 10.1007/s10549-021-06339-9. Epub 2021 Sep 24. Breast Cancer Res Treat. 2021. PMID: 34561764 Free PMC article.
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.
Choucair A, Pham TH, Omarjee S, Jacquemetton J, Kassem L, Trédan O, Rambaud J, Marangoni E, Corbo L, Treilleux I, Le Romancer M. Choucair A, et al. Among authors: corbo l. Oncogene. 2019 May;38(21):4015-4027. doi: 10.1038/s41388-019-0694-9. Epub 2019 Jan 28. Oncogene. 2019. PMID: 30692633 Free PMC article.
96 results